These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 11352748)
1. Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase. Patricelli MP; Cravatt BF Biochemistry; 2001 May; 40(20):6107-15. PubMed ID: 11352748 [TBL] [Abstract][Full Text] [Related]
2. Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties. Patricelli MP; Lovato MA; Cravatt BF Biochemistry; 1999 Aug; 38(31):9804-12. PubMed ID: 10433686 [TBL] [Abstract][Full Text] [Related]
3. Clarifying the catalytic roles of conserved residues in the amidase signature family. Patricelli MP; Cravatt BF J Biol Chem; 2000 Jun; 275(25):19177-84. PubMed ID: 10764768 [TBL] [Abstract][Full Text] [Related]
4. Evidence for distinct roles in catalysis for residues of the serine-serine-lysine catalytic triad of fatty acid amide hydrolase. McKinney MK; Cravatt BF J Biol Chem; 2003 Sep; 278(39):37393-9. PubMed ID: 12734197 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. Lichtman AH; Hawkins EG; Griffin G; Cravatt BF J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702 [TBL] [Abstract][Full Text] [Related]
10. Structure-based design of a FAAH variant that discriminates between the N-acyl ethanolamine and taurine families of signaling lipids. McKinney MK; Cravatt BF Biochemistry; 2006 Aug; 45(30):9016-22. PubMed ID: 16866346 [TBL] [Abstract][Full Text] [Related]
11. A second fatty acid amide hydrolase with variable distribution among placental mammals. Wei BQ; Mikkelsen TS; McKinney MK; Lander ES; Cravatt BF J Biol Chem; 2006 Dec; 281(48):36569-78. PubMed ID: 17015445 [TBL] [Abstract][Full Text] [Related]
13. Computational insights into function and inhibition of fatty acid amide hydrolase. Palermo G; Rothlisberger U; Cavalli A; De Vivo M Eur J Med Chem; 2015 Feb; 91():15-26. PubMed ID: 25240419 [TBL] [Abstract][Full Text] [Related]
14. Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization. Patricelli MP; Lashuel HA; Giang DK; Kelly JW; Cravatt BF Biochemistry; 1998 Oct; 37(43):15177-87. PubMed ID: 9790682 [TBL] [Abstract][Full Text] [Related]
15. Nonempirical energetic analysis of reactivity and covalent inhibition of fatty acid amide hydrolase. Chudyk EI; Dyguda-Kazimierowicz E; Langner KM; Sokalski WA; Lodola A; Mor M; Sirirak J; Mulholland AJ J Phys Chem B; 2013 Jun; 117(22):6656-66. PubMed ID: 23654226 [TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid hydrolases. Ueda N Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():521-34. PubMed ID: 12432941 [TBL] [Abstract][Full Text] [Related]
17. Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. Bisogno T; De Petrocellis L; Di Marzo V Curr Pharm Des; 2002; 8(7):533-47. PubMed ID: 11945157 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors. Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384 [TBL] [Abstract][Full Text] [Related]
19. Manipulation of the active site loops of D-hydantoinase, a (beta/alpha)8-barrel protein, for modulation of the substrate specificity. Cheon YH; Park HS; Kim JH; Kim Y; Kim HS Biochemistry; 2004 Jun; 43(23):7413-20. PubMed ID: 15182184 [TBL] [Abstract][Full Text] [Related]